Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

05-28

InnoModels: What are the advantages of CDX modeling platform?

In the field of biomedicine, cancer research has always been an important topic that scientists are constantly striving to overcome. With the continuous advancement of technology, more and more innovative methods have been applied to this field, among which the CDX modeling platform of InnoModels Biotechnology provides strong support for cancer research and drug development with its unique advantages.

05-27

InnoModels Biotechnology: What are the features of PDC high-throughput in vitro drug efficacy platform?

With the rapid development of medical science and technology, the R&D process of new drugs is increasingly demanding in terms of efficiency, accuracy and cost. Against this backdrop, the InnoModels Biotechnology PDC platform has emerged to revolutionize the field of new drug discovery and development with its unique technological advantages. In this paper, we will introduce the features of the InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform in detail, in order to reveal its important value in drug research.

05-24

InnoModels Biotechnology: What are the features of the ADCC platform?

In the field of biomedicine, research targeting tumor immunotherapy has always been at the forefront of scientists' continuous exploration and breakthroughs. Among them, antibody-dependent cytotoxicity (ADCC), as a key process in natural immune response, has high research value and clinical application potential. With its unique ADCC platform, InnoModels Biotechnology provides powerful and comprehensive support for tumor immunotherapy research.

05-23

InnoModels Biotechnology: What are the advantages of the CDX modeling platform?

In the vast field of biomedical research, cancer research has always been an important challenge for scientists. In order to better understand the biology of cancer and find effective treatments, the InnoModels Bio CDX modeling platform has emerged to provide strong support for cancer research and drug development with its unique features and advantages.

< 1...20 21 22...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License